Of special interest for men (from WedMD):
BPH Drugs Linked to
Increased Prostate Cancer Risk
The FDA is requiring makers of drugs used to treat BPH (benign prostatic hyperplasia) --
a condition with symptoms that include urination trouble due to an enlarged prostate gland --
to change labeling due to increased risk of a serious form of prostate cancer. The drugs
are sold under the brand names Proscar, Propecia, Avodart, and Jalyn.
Increased Prostate Cancer Risk
The FDA is requiring makers of drugs used to treat BPH (benign prostatic hyperplasia) --
a condition with symptoms that include urination trouble due to an enlarged prostate gland --
to change labeling due to increased risk of a serious form of prostate cancer. The drugs
are sold under the brand names Proscar, Propecia, Avodart, and Jalyn.
No comments:
Post a Comment